Crossmark

Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report

Published Online: 2021-09-10

Published Print: 2021-12

Authors

Brewer, Danielle

MacMillan, Margaret L.

Schleiss, Mark R.

Ayuthaya, Satja Issaranggoon Na

Young, Jo-Anne

Ebens, Christen L. https://orcid.org/0000-0003-2430-911X
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (KL2TR002492)
License Information

Text and Data Mining valid from 2021-09-10

Version of Record valid from 2021-09-10
More Information

Article History

Received: 14 May 2021

Accepted: 1 September 2021

First Online: 10 September 2021

Declarations

:

: The patient’s care was provided on a University of Minnesota IRB approved allogeneic hematopoietic cell transplant protocol.

: Verbal and written consent for publication of de-identified clinical data was obtained from the patient’s parent with the patient’s assent.

: The authors report no competing interests.

Document is current